Occupational exposure to blood and body fluids: new postexposure prophylaxis recommendations. United States Occupational Safety and Health Administration.
Dental health care professionals continue to suffer exposure incidents from instruments contaminated with blood and/or body fluids from patients. Each of these cases requires that a rigid protocol be followed for their evaluation. New information regarding the risk factors for HIV-seroconversion following an exposure incident have been identified. Recent data has demonstrated that a 79 percent reduction in disease transmission may be possible with a new combination drug therapy. The anti-retroviral drugs included in this new regimen are now standard in the management of occupational exposure to HIV. Several factors set dentistry apart from other health care occupations, and these differences appear to have an effect on the risks associated with occupational exposures. This article explores these risk factors and the new recommendations for postexposure care.
Cuny
E
E
University of the Pacific School of Dentistry, San Francisco, CA 94115, USA.
Carpenter
W M
WM
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D017848:Blood-Borne Pathogens; D003797:Dental Staff; D003813:Dentistry; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D019469:Indinavir / Q000627:therapeutic use; D017758:Infectious Disease Transmission, Patient-to-Professional / Q000517:prevention & control*; D019259:Lamivudine / Q000627:therapeutic use; D019221:Mandatory Reporting; D016273:Occupational Exposure; D012307:Risk Factors; D012308:Risk Management; D011795:Surveys and Questionnaires; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D019259:Lamivudine; D015215:Zidovudine; D019469:Indinavir